Journal profile

Indian journal of cancer

Publisher: Medknow Publications
ISSN0019-509X | 1998-4774 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.37
Citation rate 0.77 140 total citations
h5-index 18 h5 depth signal
Cited share 41.5% 80 of 193
Total citations 140 Citation footprint
Metric signal 0.76 External metric anchor
Self-citation 0.7% 1 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

India 906
China 81
Turkey 77
United States 25
Iran 24

Citing Fields of Research

Oncology 508
Breast Cancer 140
Lung Cancer 137
Musculoskeletal & Nerve Cancer 80
Liver & Colon Cancer 76

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 2,508 Articles tracked across the journal lifetime
Indexed publication set 193 80 cited publications
Last 12 months 42 14.0 publications/month
Open access share 100.0% 42 OA publications in the last year
Leading citing country India 906 citing publications
Leading citing field Oncology 508 citing publications
Latest tracked publication 1 April 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v2n1,Mar. 1965-
PubMed
v2n1,Mar. 1965-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Oncology Musculoskeletal & Nerve Cancer Lung Cancer Hematology Breast Cancer Palliative Care

Issuing & Sponsoring Bodies

Contributor
Indian Cancer Society

Broad Categories

Neoplasms Musculoskeletal & Nerve Cancer Breast Cancer Oncology Hematology Lymphomas Reproductive Health Lung Cancer

MeSH Descriptors

Neoplasms

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Anuradha Mehta, Debdeep Samaddar, Prabhat Bhargava et al.
Background: Hormone receptor-positive (HR+)/HER2-negative (HER2−) early breast cancer (EBC) is associated with a persistent risk of recurrence despite optimal local therapy and adjuvant endocrine therapy, particularly in patients with hi...
04
Sukhjot Kaur, Zohra Khatoon
This article offers a comprehensive analysis and updates using GLOBOCAN 2022, Cancer Atlas, National Cancer Registry Programme 2022, and many more available sources for information on cancer incidence and deaths in 2022 and their project...
06
Rachana Chennamaneni, Meher L. Konatam, Sadashivudu Gundeti et al.
Background: Gastric cancer ranks as the fifth most prevalent malignancy worldwide. Although predominantly affecting individuals aged 50–70 years, a small proportion presents at a younger age, often displaying distinct biological behavior...
09
Anupama S. Borker, Darshan J Kanani
Background: While the survival of childhood acute lymphoblastic leukemia (ALL) approaches 90% in developed nations, outcomes in developing countries are much lower. Methods: We conducted a retrospective analysis of the first 50 patients ...
10
Pushpa, Madhu Dayal, Sakshi Khandelwal et al.
Background: Sleep disturbances and fatigue are common in patients with head and neck cancer and adversely affect quality of life. Melatonin may improve sleep quality with minimal adverse effects. This study evaluated the effect of oral m...

Bibliographical & Catalog Notes

Supplements accompany some issues.

Also issued online.